GlassScriptPhysician profile
Getinet Abebe Kassa
NPI 1629331855
$1,265.41
in general payments reported to CMS, 2019-2025
22 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $209 · 2021: $46.49 · 2022: $102 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $183.25 | 2019-2020 | |
| Ucb, INC. | $148.28 | 2019-2020 | |
| Amgen INC. | $105.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $103.31 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $94.13 | 2019-2020 | |
| Allergan, INC. | $89.36 | 2021-2022 | |
| Neurelis, INC. | $83.75 | 2022-2025 | Valtoco |
| Supernus Pharmaceuticals, INC. | $71.27 | 2019-2020 | |
| Lilly USA, LLC | $61.24 | 2025 | Kisunla, Amyvid |
| Biogen, INC. | $48.83 | 2019-2020 | |
| Abbvie INC. | $43.86 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Acadia Pharmaceuticals INC | $26.27 | 2019 | |
| Avanir Pharmaceuticals, INC. | $25.86 | 2019 | |
| Smith+Nephew, INC. | $23.59 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adamas Pharmaceuticals, INC. | $21.81 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.55 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $21.29 | 2025 | Wainua |
| Horizon Therapeutics Plc | $18.59 | 2021 | |
| Globus Medical, INC. | $17.46 | 2025 | Senza |
| Insightec,INC | $13.69 | 2025 | Exablate |
| Lundbeck LLC | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Getinet Kassa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.